Systemic Lupus Erythematosus: Immunologic Features

The Autoimmune Diseases, Fourth Edition

Volumn , Issue , 2006, Pages 357,XII-367,XII

  Kang, Insoo ^a   Craft, Joe ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 78651414541     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012595961-2/50031-7     Document Type: Chapter

References (164)

1. P. Ahmad-Nejad, H. Hacker, M. Rutz, S. Bauer, R.M. Vabulas and H. Wagner (2002) Bacterial CpG-DNA and lipopolysaccharides activate Toll-like receptors at distinct cellular compartments. Eur. J. Immunol. 32 1958-1968.
2. D.G. Ando, E.E. Sercarz and B.H. Hahn (1987) Mechanisms of T and B cell collaboration in the in vitro production of anti-DNA antibodies in the NZB/NZW F1 murine SLE model. The. J. Immunol. 138 3185-3190.
3. E. Arce, D.G. Jackson, M.A. Gill, L.B. Bennett, J. Banchereau and V. Pascual (2001) Increased frequency of pre-germinal center B cells and plasma cell precursors in the blood of children with systemic lupus erythematosus. J. Immunol. 167 2361-2369.
4. E.C. Baechler, F.M. Batliwalla, G. Karypis, P.M. Gaffney, W.A. Ortmann, K.J. Espe, K.B. Shark, W.J. Grande, K.M. Hughes, V. Kapur, P.K. Gregersen and T.W. Behrens (2003) Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc. Natl. Acad. Sci. U.S.A. 100 2610-2615.
5. E.C. Baechler, P.K. Gregersen and T.W. Behrens (2004) The emerging role of interferon in human systemic lupus erythematosus. Curr. Opin. Immunol. 16 801-807.
6. D.A. Bell, B. Morrison and P. VandenBygaart (1990) Immunogenic DNA-related factors. Nucleosomes spontaneously released from normal murine lymphoid cells stimulate proliferation and immunoglobulin synthesis of normal mouse lymphocytes. J. Clin. Invest. 85 1487-1496.
7. L. Bennett, A.K. Palucka, E. Arce, V. Cantrell, J. Borvak, J. Banchereau and V. Pascual (2003) Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J. Exp. Med. 197 711-723.
8. K.A. Bernstein, R.D. Valerio and J.B. Lefkowith (1995) Glomerular binding activity in MRL Ipr serum consists of antibodies that bind to a DNA/histone/type IV collagen complex. J. Immunol. 154 2424-2433.
9. R.M. Blaese, J. Grayson and A.D. Steinberg (1980) Increased immunoglobulin-secreting cells in the blood of patients with active systemic lupus erythematosus. Am. J. Med. 69 345-350.
10. P. Blanco, A.K. Palucka, M. Gill, V. Pascual and J. Banchereau (2001) Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus. Science 294 1540-1543.
11. S. Bolland and J.V. Ravetch (2000) Spontaneous autoimmune disease in Fe(gamma)RIIB-deficient mice results from strain-specific epistasis. Immunity 13 277-285.
12. D.T. Boumpas, R. Furie, S. Manzi, G.G. Illei, D.J. Wallace, J.E. Balow and A. Vaishnaw (2003) A short course of BG9588 (anti-CD40 ligand antibody) improves serologic activity and decreases hematuria in patients with proliferative lupus glomerulonephritis. Arthritis Rheum. 48 719-727.
13. F. Bouzahzah, S. Jung and J. Craft (2003) CD4+ T cells from lupusprone mice avoid antigen-specific tolerance induction in vivo. J. Immunol. 170 741-748.
14. V.M. Budagyan, E.G. Bulanova, N.I. Sharova, M.F. Nikonova, M.L. Stanislav and A.A. Yarylin (1998) The resistance of activated T-cells from SLE patients to apoptosis induced by human thymic stromal cells. Immunol. Letts 60 1.
15. B.W. Busser, B.S. Adair, J. Erikson and T.M. Laufer (2003) Activation of diverse repertoires of autoreactive T cells enhances the loss of anti-dsDNA B cell tolerance. J. Clin. Invest. 112 1361-1371.
16. O. Chan and M.J. Shlomchik (1998) A new role for B cells in systemic autoimmunity: B cells promote spontaneous T cell activation in MRL-lpr/lpr mice. J. Immunol. 160 51-59.
17. O.T. Chan, L.G. Hannum, A.M. Haberman, M.P. Madaio and M.J. Shlomchik (1999) A novel mouse with B cells but lacking serum antibody reveals an antibody-independent role for B cells in murine lupus. J. Exp. Med. 189 1639-1648.
18. B. Charpentier, C. Carnaud and J.F. Bach (1979) Selective depression of the xenogeneic cell-mediated lympholysis in systemic lupus erythematosus. J. Clin. Invest. 64 351-360.
19. R. Clynes, C. Dumitru and J.V. Ravetch (1998) Uncoupling of immune complex formation and kidney damage in autoimmune glomerulonephritis. Science 279 1052-1054.
20. P.J. Coffer and B.M. Burgering (2004) Forkhead-box transcription factors and their role in the immune system. Nat. Rev. Immunol. 4 889-899.
21. J. Craft, S. Peng, T. Fujii, M. Okada and S. Fatenejad (1999) Autoreactive T cells in murine lupus: Origins and roles in autoantibody production. Immunol. Res. 19 245-257.
22. M.K. Crow, G. DelGiudice-Asch, J.B. Zehetbauer, J.L. Lawson, N. Brot, H. Weissbach and K.B. Elkon (1994) Autoantigen-specific T cell proliferation induced by the ribosomal P2 protein in patients with systemic lupus erythematosus. J. Clin. Invest. 94 345-352.
23. M.K. Crow and K.A. Kirou (2001) Regulation of CD40 ligand expression in systemic lupus erythematosus. Curr. Opin. Rheumatol. 13 361-369.
24. M.K. Crow and K.A. Kirou (2004) Interferon-alpha in systemic lupus erythematosus. Curr. Opin. Rheumatol. 16 541-547.
25. A. Csiszar, G. Nagy, P. Gergely, T. Pozsonyi T> and E. Pocsik (2000) Increased interferon-gamma (IFN-gamma). IL-10 and decreased IL-4 mRNA expression in peripheral blood mononuclear cells (PBMC) from patients with systemic lupus erythematosus (SLE). Clin. Exp. Immunol. 122 464-470.
26. D.I. Daikh, B.K. Finck, P.S. Linsley, D. Hollenbaugh and D. Wofsy (1997) Long-term inhibition of murine lupus by brief simultaneous blockade of the B7/CD28 and CD40/gp39 costimulation pathways. J. Immunol. 159 3104-3108.
27. M. Dalod, T. Hamilton, R. Salomon, T.P. Salazar-Mather, S.C. Henry, J.D. Hamilton and C.A. Biron (2003) Dendritic cell responses to early murine cytomegalovirus infection: subset functional specialization and differential regulation by interferon alpha/beta. J. Exp. Med. 197 885-898.
28. H. Dang and R.J. Harbeck (1984) The in vivo and in vitro glomerular deposition of isolated anti-double-stranded-DNA antibodies in NZB/W mice. Clin. Immunol. Immunopathol. 30 265-278.
29. A. Davidson, A. Mannheimer-Lory, C. Aranow, R. Peterson, N. Hannigan and B. Diamond (1990) Molecular characterization of a somatically mutated anti-DNA antibody bearing two SLE related idiotypes. J. Clin. Invest. 85 1401-1409.
30. L.A. DeGiorgio, K.N. Konstantinov, S.C. Lee, J.A. Hardin, B.T. Volpe and B. Diamond (2001) A subset of lupus anti-DNA antibodies crossreacts with the NR2 glutamate receptor in systemic lupus erythematosus. Nat. Med. 7 1189-1193.
31. H.R. Deicher, H.R. Holman and H.G. Kunkel (1959) The precipitin reaction between DNA and a serum factor in SLE. J. Exp. Med. 109 97.
32. B. Deocharan, X. Qing, J. Lichauco and C. Putterman (2002) Alphaactinin is a cross-reactive renal target for pathogenic anti-DNA antibodies. J. Immunol. 168 3072-3078.
33. A. Desai-Mehta, L. Lu, R. Ramsey-Goldman and S.K. Datta (1996) Hyperexpression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production. J. Clin. Invest. 97 2063-2073.
34. A. Desai-Mehta, C. Mao, S. Rajagopalan, T. Robinson and S.K. Datta (1995) Structure and specificity of T cell receptors expressed by potentially pathogenic anti-DNA autoantibody-inducing T cells in human lupus. J. Clin. Invest. 95 531-541.
35. R. Di Valerio, K.A. Bernstein, E. Varghese and J.B. Lefkowith (1995) Murine lupus glomerulotropic monoclonal antibodies exhibit differing specificities but bind via a common mechanism. J. Immunol. 155 2258-2268.
36. S.S. Diebold, T. Kaisho, H. Hemmi, S. Akira and C. Reis e Sousa (2004) Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 303 1529-1531.
37. H.A. Doyle and M.J. Mamula (2001) Post-translational protein modifications in antigen recognition and autoimmunity. Trends Immunol. 22 443-449.
38. G.S. Early, W. Zhao and C.M. Burns (1996) Anti-CD40 ligand antibody treatment prevents the development of lupus-like nephritis in a subset of New Zealand black × New Zealand white mice. Response correlates with the absence of an anti-antibody response. J. Immunol. 157 3159-3164.
39. K.B. Elkon (1994) Apoptosis in SLE: too little or too much? Clin. Exp. Rheumatol. 12 553.
40. M.R. Elliott, R.A. Shanks, I.U. Khan, J.W. Brooks, P.J. Burkett, B.J. Nelson, V. Kyttaris, Y.T. Juang, G.C. Tsokos and G.M. Kammer (2004) Down-regulation of IL-2 production in T lymphocytes by phosphorylated protein kinase A-RIIbeta. J. Immunol. 172 7804-7812.
41. W. Emlen and M. Mannik (1982) Clearance of circulating DNA-anti-DNA immune complexes in mice. J. Exp. Med. 155 1210-1215.
42. W. Emlen, J. Niebur and R. Kadera (1994) Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus. J. Immunol. 152 3685-3692.
43. E.J. Enyedy, M.P. Nambiar, S.N. Liossis, G. Dennis, G.M. Kammer and G.C. Tsokos (2001) Fc epsilon receptor type 1 gamma chain replaces the deficient T cell receptor zeta chain in T cells of patients with systemic lupus erythematosus. Arthritis Rheum. 44 1114-1121.
44. P. Faaber, T.P. Rijke, L.B. van de Putte, P.J. Capel and J.H. Berden (1986) Cross-reactivity of human and murine anti-DNA antibodies with heparan sulfate. The major glycosaminoglycan in glomerular basement membranes. J. Clin. Invest. 77 1824-1830.
45. S. Fatenejad, S.L. Peng, O. Disorbo and J. Craft (1998) Central T cell tolerance in lupus-prone mice: influence of autoimmune background and the Ipr mutation. J. Immunol. 161 6427-6432.
46. B.K. Finck, P.S. Linsley and D. Wofsy (1994) Treatment of murine lupus with CTLA4Ig. Science 265 1225-1227.
47. G.J. Friou (1957) Clinical application of lupus serum; nucleoprotein reaction using fluorescent antibody technique. J. Clin. Invest. 36 890.
48. H. Fukuyama, F. Nimmerjahn and J.V. Ravetch (2005) The inhibitory Fegamma receptor modulates autoimmunity by limiting the accumulation of immunoglobulin G+ anti-DNA plasma cells. Nat. Immunol. 6 99-106.
49. G.S. Gilkeson (1999) Glomerular binding antibodies in systemic lupus erythematosus. G.M. Kammer, G.C. Tsokos (Eds) Lupus: Molecular and Cellular Pathogenesis Totowa, N.J.: Humana Press
50. A.C. Grammer, R. Slota, R. Fischer, H. Gur, H. Girschick, C. Yarboro, G.G. Illei and P.E. Lipsky (2003) Abnormal germinal center reactions in systemic lupus erythematosus demonstrated by blockade of CD154-CD40 interactions. J. Clin. Invest. 112 1506-1520.
51. Y. Harada, M.M. Kawano, N. Huang, M.S. Mahmoud, I.A. Lisukov, K. Mihara, T. Tsujimoto T> and A. Kuramoto (1996) Identification of early plasma cells in peripheral blood and their clinical significance. Br. J. Haematol. 92 184-191.
52. B. Hecht, N. Siegel, M. Adler, M. Kashgarian and J.P. Hayslett (1976) Prognostic indices in lupus nephritis. Medicine (Baltimore) 55 163-181.
53. F. Heil, H. Hemmi, H. Hochrein, F. Ampenberger, C. Kirschning, S. Akira, G. Lipford, H. Wagner and S. Bauer (2004) Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 303 1526-1529.
54. P. Hermann, M. Rubio, T. Nakajima, G. Delespesse and M. Sarfati (1998) IFN-alpha priming of human monocytes differentially regulates gram-positive and gram-negative bacteria-induced IL-10 release and selectively enhances IL-12p70, CD80, and MHC class I expression. J. Immunol. 161 2011-2018.
55. R.W. Hoffman (2004) T cells in the pathogenesis of systemic lupus erythematosus. Clin. Immunol. 113 4-13.
56. R.W. Hoffman, Y. Takeda, G.C. Sharp, D.R. Lee, D.L. Hill, H. Kaneoka and C.W. Caldwell (1993) Human T cell clones reactive against U-small nuclear ribonucleoprotein autoantigens from connective tissue disease patients and healthy individuals. J. Immunol. 151 6460-6469.
57. H.R. Holman and H.G. Kunkel (1957) Affinity between the lupus erythematosus serum factor and cell nuclei and nucleoprotein. Science 126 162.
58. J.J. Hooks, H.M. Moutsopoulos, S.A. Geis, N.I. Stahl, J.L. Decker and A.L. Notkins (1979) Immune interferon in the circulation of patients with autoimmune disease. N. Engl. J. Med. 301 5-8.
59. F.A. Houssiau, C. Lefebvre, M. Vanden Berghe, M. Lambert, J.P. Devogelaer and J.C. Renauld (1995) Serum interleukin 10 titers in systemic lupus erythematosus reflect disease activity. Lupus 4 393-395.
60. W. Huang, J. Sinha, J. Newman, B. Reddy, L. Budhai, R. Furie, A. Vaishnaw and A. Davidson (2002) The effect of anti-CD40 ligand antibody on B cells in human systemic lupus erythematosus. Arthritis Rheum 46 1554-1562.
61. S. Ishikawa, S. Akakura, M. Abe, K. Terashima, K. Chijiiwa, H. Nishimura, S. Hirose and T. Shirai (1998) A subset of CD4+ T cells expressing early activation antigen CD69 in murine lupus: possible abnormal regulatory role for cytokine imbalance. J. Immunol. 161 1267-1273.
62. A. Iwasaki and R. Medzhitov (2004) Toll-like receptor control of the adaptive immune responses. Nat. Immunol. 5 987-995.
63. S. Izui, P.H. Lambert and P.A. Miescher (1976) In vitro demonstration of a particular affinity of glomerular basement membrane and collagen for DNA. A possible basis for a local formation of DNA-anti-DNA complexes in systemic lupus erythematosus. J. Exp. Med. 144 428-443.
64. S. Izui, P.H. Lambert and P.A. Miescher (1977) Failure to detect circulating DNA-anti-DNA complexes by four radioimmunological methods in patients with systemic lupus erythematosus. Clin. Exp. Immunol. 30 384-392.
65. L. Jacob, M.A. Lety, D. Louvard and J.F. Bach (1985) Binding of a monoclonal anti-DNA autoantibody to identical protein(s) present at the surface of several human cell types involved in lupus pathogenesis. J. Clin. Invest. 75 315-317.
66. A.M. Jacobi, M. Odendahl, K. Reiter, A. Bruns, G.R. Burmester, A. Radbruch, G. Valet, P.E. Lipsky and T. Dorner (2003) Correlation between circulating CD27high plasma cells and disease activity in patients with systemic lupus erythematosus. Arthritis Rheum. 48 1332-1342.
67. A.M. Jevnikar, M.J. Grusby and L.H. Glimcher (1994) Prevention of nephritis in major histocompatibility complex class II-deficient MRL-lpr mice. J. Exp. Med. 179 1137-1143.
68. J. Jongstra-Bilen, B. Vukusic, K. Boras and J.E. Wither (1997) Resting B cells from autoimmune lupus-prone New Zealand Black and (New Zealand Black × New Zealand White)F1 mice are hyper-responsive to T cell-derived stimuli. J. Immunol. 159 5810-5820.
69. Y.T. Juang, Y. Wang, E.E. Solomou, Y. Li, C. Mawrin, K. Tenbrock, V. Kyttaris and G.C. Tsokos (2005) Systemic lupus erythematosus serum IgG increases CREM binding to the IL-2 promoter and suppresses IL-2 production through CAMVIV. J. Clin. Invest. 115 996-1005.
70. E.C. Jury, P.S. Kabouridis, F. Flores-Borja, R.A.I. Mageed and D.A. Isenberg (2004) Altered lipid raft-associated signaling and ganglioside expression in T lymphocytes from patients with systemic lupus erythematosus. J. Clin. Invest. 113 1176-1187.
71. A. Kaliyaperumal, C. Mohan, W. Wu and S.K. Datta (1996) Nucleosomal peptide epitopes for nephritis-inducing T helper cells of murine lupus. J. Exp. Med. 183 2459-2469.
72. S.L. Kalled, A.H. Cutler, S.K. Datta and D.W. Thomas (1998) Anti-CD40 ligand antibody treatment of SNF1 mice with established nephritis: preservation of kidney function. J. Immunol. 160 2158-2165.
73. G.M. Kammer (2005) Altered regulation of IL-2 production in systemic lupus erythematosus: an evolving paradigm. J. Clin. Invest. 115 836-840.
74. G.M. Kammer, I.U. Khan, J.A. Kammer, L. Olorenshaw and D. Mathis (1996) Deficient type I protein kinase A isozyme activity in systemic lupus erythematosus T lymphocytes: II. Abnormal isozyme kinetics. J. Immunol. 157 2690-2698.
75. G.M. Kammer, A. Perl, B.C. Richardson and G.C. Tsokos (2002) Abnormal T cell signal transduction in systemic lupus erythematosus. Arthritis Rheum. 46 1139-1154.
76. I. Kang, T. Quan, H. Nolasco, S.H. Park, M.S. Hong, J.G. Howe and J. Craft (2004) Defective control of latent Epstein-Barr virus infection in systemic lupus erythematosus. J. Immunol. 172 1287-1294.
77. K. Kato, E. Santana-Sahagun, L.Z. Rassenti, M.H. Weisman, N. Tamura, S. Kobayashi, H. Hashimoto and T.J. Kipps (1999) The soluble CD40 ligand sCD154 in systemic lupus erythematosus. J. Clin. Invest. 104 947-955.
78. D. Koffler, P.H. Schur and H.G. Kunkel (1967) Immunological studies concerning the nephritis of systemic lupus erythematosus. J. Exp. Med. 126 607-624.
79. D.R. Koh, A. Ho, A. Rahemtulla, W.P. Fung-Leung, H. Griesser and T.W. Mak (1995) Murine lupus in MRL/Ipr mice lacking CD4 or CD8 T cells. Eur. J. Immunol. 25 2558-2562.
80. M. Koshy, D. Berger and M.K. Crow (1996) Increased expression of CD40 ligand on systemic lupus erythematosus lymphocytes. J. Clin. Invest. 98 826-837.
81. B. Kovacs, D. Vassilopoulos, S.A. Vogelgesang and G.C. Tsokos (1996) Defective CD3-mediated cell death in activated T cells from patients with systemic lupus erythematosus: role of decreased intracellular TNF-alpha. Clin. Immunol. Immunopathol. 81 293-302.
82. C. Kowal, L.A. DeGiorgio, T. Nakaoka, H. Hetherington, P.T. Huerta, B. Diamond and B.T. Volpe (2004) Cognition and immunity; antibody impairs memory. Immunity 21 179-188.
83. S. Krishnan, M.P. Nambiar, V.G. Warke, C.U. Fisher, J. Mitchell, N. Delaney and G.C. Tsokos (2004) Alterations in lipid raft composition and dynamics contribute to abnormal T cell responses in systemic lupus erythematosus. J. Immunol. 172 7821-7831.
84. A. Lanzavecchia (1995) How can cryptic epitopes trigger autoimmunity? J. Exp. Med. 181 1945-1948.
85. E.A. Leadbetter, I.R. Rifkin, A.M. Hohlbaum, B.C. Beaudette, M.J. Shlomchik and A. Marshak-Rothstein (2002) Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 416 603-607.
86. J.B. Lefkowith, R. Di Valerio, J. Norris, G.D. Glick, A.L. Alexander, L. Jackson and G.S. Gilkeson (1996) Murine glomerulotropic monoclonal antibodies are highly oligoclonal and exhibit distinctive molecular features. J. Immunol. 157 1297-1305.
87. J.B. Lefkowith and G.S. Gilkeson (1996) Nephritogenic autoantibodies in lupus: current concepts and continuing controversies. Arthritis Rheum. 39 894-903.
88. Z. Liang, C. Xie, C. Chen, D. Kreska, K. Hsu, L. Li, X. Zhou and C. Mohan (2004) Pathogenic profiles and molecular signatures of anti-nuclear autoantibodies rescued from NZM2410 lupus mice. J. Exp. Med. 199 381-398.
89. S.N. Liossis, X.Z. Ding, G.J. Dennis and G.C. Tsokos (1998) Altered pattern of TCR/CD3-mediated protein-tyrosyl phosphorylation in T cells from patients with systemic lupus erythematosus. Deficient expression of the T cell receptor zeta chain. J. Clin. Invest. 101 1448-1457.
90. S.N. Liossis, B. Kovacs, G. Dennis, G.M. Kammer and G.C. Tsokos (1996) B cells from patients with systemic lupus erythematosus display abnormal antigen receptor-mediated early signal transduction events. J. Clin. Invest. 98 2549-2557.
91. M.F. Liu, C.R. Wang, L.L. Fung and C.R. Wu (2004) Decreased CD4+CD25+ T cells in peripheral blood of patients with systemic lupus erythematosus. Scand. J. Immunol. 59 198-202.
92. L. Llorente, Y. Richaud-Patin, R. Fior, J. Alcocer-Varela, J. Wijdenes, B.M. Fourrier, P. Galanaud and D. Emilie (1994) In vivo production of interleukin-10 by non-T cells in rheumatoid arthritis, Sjogren's syndrome, and systemic lupus erythematosus. A potential mechanism of B lymphocyte hyperactivity and autoimmunity. Arthritis Rheum. 37 1647-1655.
93. L. Llorente, Y. Richaud-Patin, J. Wijdenes, J. Alcocer-Varela, M.C. Maillot, I. Durand-Gasselin, B.M. Fourrier, P. Galanaud and D. Emilie (1993) Spontaneous production of interleukin-10 by B lymphocytes and monocytes in systemic lupus erythematosus. Eur. Cytokine Netw. 4 421-427.
94. L. Llorente, W. Zou, Y. Levy, Y. Richaud-Patin, J. Wijdenes, J. Alcocer-Varela, B. Morel-Fourrier, J.C. Brouet, D. Alarcon-Segovia, P. Galanaud and D. Emilie (1995) Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus. J. Exp. Med. 181 839-844.
95. L. Lu, A. Kaliyaperumal, D.T. Boumpas and S.K. Datta (1999) Major peptide autoepitopes for nucleosome-specific T cells of human lupus. J. Clin. Invest. 104 345-355.
96. J. Ma, J. Xu, Q. Peng, J. Zhang, I.S. Grewal, R.A. Flavell and J. Craft (1996) Autoimmune lpr/lpr mice deficient in CD40 ligand: spontaneous immunoglobulin class switching with dichotomy of autoantibody responses. J. Immunol. 157 417-426.
97. M.P. Madaio, J. Carlson, J. Cataldo, A. Ucci, P. Migliorini and O. Pankewyez (1987) Murine monoclonal anti-DNA antibodies bind directly to glomerular antigens and form immune deposits. J. Immunol. 138 2883-2889.
98. T.N. Marion, D.M. Tillman and N. Jou (1990) Interclonal and intraclonal diversity among anti-DNA antibodies from an (NZB × NZW)F1 mouse. J. Immunol. 145 2322-2332.
99. L.J. Mason, C.T. Ravirajan, A. Rahman, C. Putterman and D.A. Isenberg (2004) Is alpha-actinin a target for pathogenic anti-DNA antibodies in lupus nephritis? Arthritis Rheum. 50 866-870.
100. K.H. Mills (2004) Regulatory T cells: friend or foe in immunity to infection? Nat. Rev. Immunol. 4 841-855.
101. C. Mohan, S. Adams, V. Stanik and S.K. Datta (1993) Nucleosome: a major immunogen for pathogenic autoantibody-inducing T cells of lupus. J. Exp. Med. 177 1367-1381.
102. C. Mohan, L. Morel, P. Yang, H. Watanabe, B. Croker, G. Gilkeson and E.K. Wakeland (1999) Genetic dissection of lupus pathogenesis: a recipe for nephrophilic autoantibodies. J. Clin. Invest. 103 1685-1695.
103. C. Mohan, Y. Shi, J.D. Laman and S.K. Datta (1995) Interaction between CD40 and its ligand gp39 in the development of murine lupus nephritis. J. Immunol. 154 1470-1480.
104. L. Morel, C. Mohan, Y. Yu, B.P. Croker, N. Tian, A. Deng and E.K. Wakeland (1997) Functional dissection of systemic lupus erythematosus using congenic mouse strains. J. Immunol. 158 6019-6028.
105. G. Mostoslavsky, R. Fischel, N. Yachimovich, Y. Yarkoi, E. Rosenmann, M. Monestier, M. Baniyash and D. Eilat (2001) Lupus anti-DNA autoantibodies cross-react with a glomerular structural protein: a case for tissue injury by molecular mimicry. Eur. J. Immunol. 31 1221-1227.
106. M. Odendahl, A. Jacobi, A. Hansen, E. Feist, F. Hiepe, G.R. Burmester, P.E. Lipsky, A. Radbruch and T. Dorner (2000) Disturbed peripheral B lymphocyte homeostasis in systemic lupus erythematosus. J. Immunol. 165 5970-5979.
107. T.L. O'Keefe, S. Bandyopadhyay, S.K. Datta and T. Imanishi-Kari (1990) V region sequences of an idiotypically connected family of pathogenic anti-DNA autoantibodies. J. Immunol. 144 4275-4283.
108. T.L. O'Keefe, G.T. Williams, F.D. Batista and M.S. Neuberger (1999) Deficiency in CD22, a B cell-specific inhibitory receptor, is sufficient to predispose to development of high affinity autoantibodies. J. Exp. Med. 189 1307-1313.
109. T.L. O'Keefe, G.T. Williams, S.L. Davies and M.S. Neuberger (1996) Hyperresponsive B cells in CD22-deficient mice. Science 274 798-801.
110. Y.B. Park, S.K. Lee, D.S. Kim, J. Lee, C.H. Lee and C.H. Song (1998) Elevated interleukin-10 levels correlated with disease activity in systemic lupus erythematosus. Clin. Exp. Rheumatol. 16 283-288.
111. C. Pasare and R. Medzhitov (2003) Toll-like receptors: balancing host resistance with immune tolerance. Curr. Opin. Immunol. 15 677-682.
112. S.L. Peng, S. Fatenejad and J. Craft (1996) Induction of non-pathologic, humoral autoimmunity in lupus-prone mice by a class II-restricted, transgenic ab T cell: separation of autoantigen-specific and-nonspecific help. J. Immunol. 157 5225-5230.
113. S.L. Peng, M.P. Madaio, D.P. Hughes, I.N. Crispe, M.J. Owen, L. Wen, A.C. Hayday and J. Craft (1996) Murine lupus in the absence of alpha beta T cells. J. Immunol. 156 4041-4049.
114. S.L. Peng, J.M. McNiff, M.P. Madaio, J. Ma, M.J. Owen, R.A. Flavell, A.C. Hayday and J. Craft (1997) ab T cell regulation and CD40 ligand dependence in murine systemic autoimmunity. J. Immunol. 158 2464-2470.
115. E.F. Petricoin 3rd, S. Ito, B.L. Williams, S. Audet, L.F. Stancato, A. Gamero, K. Clouse, P. Grimley, A. Weiss, J. Beeler, D.S. Finbloom, E.W. Shores, R. Abraham and A.C. Larner (1997) Antiproliferative action of interferon-alpha requires components of T-cell-receptor signalling. Nature 390 629-632.
116. F. Powrie and K.J. Maloy (2003) Immunology. Regulating the regulators. Science 299 1030-1031.
117. L.G. Radvanyi, A. Banerjee, M. Weir and H. Messner (1999) Low levels of interferon-alpha induce CD86 (B7.2) expression and accelerates dendritic cell maturation from human peripheral blood mononuclear cells. Scand. J. Immunol. 50 499-509.
118. S. Rajagopalan, T. Zordan, G.C. Tsokos and S.K. Datta (1990) Pathogenic anti-DNA autoantibody-inducing T helper cell lines from patients with active lupus nephritis: isolation of CD4-8-T helper cell lines that express the gamma delta T-cell antigen receptor. Proc. Natl. Acad. Sci. U.S.A. 87 7020-7024.
119. E. Raz, H. Ben-Bassat, T. Davidi, Z. Shlomai and D. Eilat (1993) Cross-reactions of anti-DNA autoantibodies with cell surface proteins. Eur. J. Immunol. 23 383-390.
120. E. Raz, M. Brezis, E. Rosenmann and D. Eilat (1989) Anti-DNA anti-bodies bind directly to renal antigens and induce kidney dysfunction in the isolated perfused rat kidney. J. Immunol. 142 3076-3082.
121. J.P. Reeves, J.D. Taurog and A.D. Steinberg (1981) Polyclonal B-cell activation of autoantibodies (CBA/N × NZB)F1 mice by polyinosinic polycytidylic acid. Clin. Immunol. Immunopathol. 19 170-180.
122. L. Reininger, T. Radaszkiewicz, M. Kosco, F. Melchers and A.G. Rolink (1992) Development of autoimmune disease in SCID mice populated with long-term “in vitro” proliferating (NZB × NZW)F1 pre-B cells. J. Exp. Med. 176 1343-1353.
123. J.H. Roark, C.L. Kuntz, K.A. Nguyen, A.J. Caton and J. Erikson (1995) Breakdown of B cell tolerance in a mouse model of systemic lupus erythematosus. J. Exp. Med. 181 1157-1167.
124. J.H. Roark, C.L. Kuntz, K.A. Nguyen, L. Mandik, M. Cattermole and J. Erikson (1995) B cell selection and allelic exclusion of an anti-DNA Ig transgene in MRL-lpr/lpr mice. J. Immunol. 154 4444-4455.
125. L. Ronnblom and G.V. Alm (2001) An etiopathogenic role for the type I IFN system in SLE. Trends Immunol. 22 427-431.
126. L. Ronnblom and G.V. Alm (2001) A pivotal role for the natural interferon alpha-producing cells (plasmacytoid dendritic cells) in the pathogenesis of lupus. J. Exp. Med. 194 F59-F63.
127. J. Ronnelid, A. Tejde, L. Mathsson, K. Nilsson-Ekdahl and B. Nilsson (2003) Immune complexes from SLE sera induce IL10 production from normal peripheral blood mononuclear cells by an FegammaRII dependent mechanism: implications for a possible vicious cycle maintaining B cell hyperactivity in SLE. Ann. Rheum. Dis. 62 37-42.
128. S.J. Rozzo, C.G. Drake, B.L. Chiang, M.E. Gershwin and B.L. Kotzin (1994) Evidence for polyclonal T cell activation in murine models of systemic lupus erythematosus. J. Immunol. 153 1340-1351.
129. L. Rui, C.G. Vinuesa, J. Blasioli and C.C. Goodnow (2003) Resistance to CpG DNA-induced autoimmunity through tolerogenic B cell antigen receptor ERK signaling. Nat. Immunol. 4 594-600.
130. H. Sabzevari, S. Propp, D.H. Kono and A.N. Theofilopoulos (1997) G1 arrest and high expression of cyclin kinase and apoptosis inhibitors in accumulated activated/memory phenotype CD4+ cells of older lupus mice. Eur. J. Immunol. 27 1901-1910.
131. H. Sano and C. Morimoto (1981) Isolation of DNA from DNA/anti-DNA antibody immune complexes in systemic lupus erythematosus. J. Immunol. 126 538-539.
132. M.L. Santiago-Raber, R. Baccala, K.M. Haraldsson, D. Choubey, T.A. Stewart, D.H. Kono and A.N. Theofilopoulos (2003) Type-I interferon receptor deficiency reduces lupus-like disease in NZB mice. J. Exp. Med. 197 777-788.
133. T.J. Santoro, J.P. Portanova and B.L. Kotzin (1988) The contribution of L3T4+ T cells to lymphoproliferation and autoantibody production in MRL-lpr/lpr mice. J. Exp. Med. 167 1713-1718.
134. T.M. Schmiedeke, F.W. Stockl, R. Weber, Y. Sugisaki, S.R. Batsford and A. Vogt (1989) Histones have high affinity for the glomerular basement membrane. Relevance for immune complex formation in lupus nephritis. J. Exp. Med. 169 1879-1894.
135. E.M. Shevach (2000) Regulatory T cells in autoimmunity. Annu. Rev. Immunol. 18 423-449.
136. M.J. Shlomchik, J.E. Craft and M.J. Mamula (2001) From T to B and back again: positive feedback in systemic autoimmune diseas. Nat. Rev. Immunol. 1 147-153.
137. M.J. Shlomchik, M.P. Madaio, D. Ni, M. Trounstein and D. Huszar (1994) The role of B cells in lpr/lpr-induced autommunity. J. Exp. Med. 180 1295-1306.
138. M.J. Shlomchik, A. Marshak-Rothstein, C.B. Wolfowicz, T.L. Rothstein and M.G. Weigert (1987) The role of clonal selection and somatic mutation in autoimmunity. Nature 328 805-811.
139. M.J. Shlomchik, M. Mascelli, H. Shan, M.Z. Radic, D. Pisetsky, A. Marshak-Rothstein and M. Weigert (1990) Anti-DNA antibodies from autoimmune mice arise by clonal expansion and somatic mutation. J. Exp. Med. 171 265-273.
140. G.G. Singer and A.K. Abbas (1994) The fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice. Immunity 1 365-373.
141. R.R. Singh, V. Kumar, F.M. Ebling, S. Southwood, A. Sette, E.E. Sercarz and B.H. Hahn (1995) T cell determinants from autoantibodies to DNA can upregulate autoimmunity in murine systemic lupus erythematosus. J. Exp. Med. 181 2017-2027.
142. E.S. Sobel, L. Morel, R. Baert, C. Mohan, J. Schiffenbauer and E.K. Wakeland (2002) Genetic dissection of systemic lupus erythematosus pathogenesis: evidence for functional expression of Sle3/5 by non-T cells. J. Immunol. 169 4025-4032.
143. A.D. Steinberg, J.B. Roths, E.D. Murphy, R.T. Steinberg and E.S. Raveche (1980) Effects of thymectomy or androgen administration upon the autoimmune disease of MRL/Mp-lpr/lpr mice. J. Immunol. 125 871-873.
144. W. Stohl (1995) Impaired polyclonal T cell cytolytic activity. A possible risk factor for systemic lupus erythematosus. Arthritis Rheum. 38 506-516.
145. E.M. Tan (1989) Antinuclear antibodies: Diagnostic markers for autoimmune diseases and probes for cell biology. Adv. Immunol. 44 93-151.
146. W.J. Tax, C. Kramers, M.C. van Bruggen and J.H. Berden (1995) Apoptosis, nucleosomes, and nephritis in systemic lupus erythematosus [editorial]. Kidney Int. 48 666-673.
147. G.C. Tsokos, M.P. Nambiar, K. Tenbrock and Y.T. Juang (2003) Rewiring the T-cell: signaling defects and novel prospects for the treatment of SLE. Trends Immunol. 24 259-263.
148. G.C. Tsokos, P.L. Smith, C.B. Christian, R.N. Lipnick, J.E. Balow and J.Y. Djeu (1985) Interleukin-2 restores the depressed allogeneic cell-mediated lympholysis and natural killer cell activity in patients with systemic lupus erythematosus. Clin. Immunol. Immunopathol. 34 379-386.
149. J. Tyrrell-Price, P.M. Lydyard and D.A. Isenberg (2001) The effect of interleukin-10 and of interleukin-12 on the in vitro production of antidouble-stranded DNA antibodies from patients with systemic lupus erythematosus. Clin. Exp. Immunol. 124 118-125.
150. R.K. Vakkalanka, C. Woo, K.A. Kirou, M. Kosby, D. Berger and M.K. Crow (1999) Elevated levels and functional capacity of soluble CD40 ligand in systemic lupus erythematosus sera. Arthritis Rheum. 42 871-881.
151. D. Vassilopoulos, B. Kovacs and G.C. Tsokos (1995) TCR/CD3 complex-mediated signal transduction pathway in T cells and T cell lines from patients with systemic lupus erythematosus. J. Immunol. 155 2269-2281.
152. G.A. Viglianti, C.M. Lau, T.M. Hanley, B.A. Miko, M.J. Shlomchik and A. Marshak-Rothstein (2003) Activation of autoreactive B cells by CpG dsDNA. Immunity 19 837-847.
153. D. Vlahakos, M.H. Foster, A.A. Ucci, K.J. Barrett, S.K. Datta and M.P. Madaio (1992) Murine monoclonal anti-DNA antibodies penetrate cells, bind to nuclei, and induce glomerular proliferation and proteinuria in vivo. J. Am. Soc. Nephrol. 2 1345-1354.
154. G. Vratsanos, I. Kang and J. Craft (2001) Systemic lupus erythematosus. K.F. Austen, M.M. Frank, J.P. Atkinson, H. Cantor (Eds) Samter's Immunologic Diseases Philadelphia: Lippincott Williams & Wilkins 475-495.
155. G.S. Vratsanos, S. Jung, Y.M. Park and J. Craft (2001) CD4(+) T cells from lupus-prone mice are hyperresponsive to T cell receptor engagement with low and high affinity peptide antigens. A model to explain spontaneous T cell activation in lupus. J. Exp. Med. 193 329-338.
156. R.J. Warrington and W.J. Rutherford (1990) Normal mitogen-induced suppression of the interleukin-6 (IL-6) response and its deficiency in systemic lupus erythematosus. J. Clin. Immunol. 10 52-60.
157. D. Wofsy, J.A. Ledbetter, P.L. Hendler and W.E. Seaman (1985) Treatment of murine lupus with monoclonal anti-T cell antibody. J. Immunol. 134 852-857.
158. H.K. Wong, G.M. Kammer, G. Dennis and G.C. Tsokos (1999) Abnormal NF-kappa B activity in T lymphocytes from patients with systemic lupus erythematosus is associated with decreased p65-RelA protein expression. J. Immunol. 163 1682-1689.
159. H. Xaio, W.A. Banks, M.L. Niehoff and J.E. Morley (2001) Effect of LPS on the permeability of the blood-brain barrier to insulin. Brain Res. 896 36-42.
160. L. Xu, L. Zhang, Y. Yi, H.K. Kang and S.K. Datta (2004) Human lupus T cells resist inactivation and escape death by upregulating COX-2. Nat. Med. 10 411-415.
161. J. Yan and M.J. Mamula (2002) Autoreactive T cells revealed in the normal repertoire: escape from negative selection and peripheral tolerance. J. Immunol. 168 3188-3194.
162. Y. Yi, M. McNerney and S.K. Datta (2000) Regulatory defects in Cbl and mitogen-activated protein kinase (extracellular signal-related kinase) pathways cause persistent hyperexpression of CD40 ligand in human lupus T cells. J. Immunol. 165 6627-6634.
163. Z. Zhao, E. Weinstein, M. Tuzova, A. Davidson, P. Mundel, P. Marambio and C. Putterman (2005) Cross-reactivity of human lupus anti-DNA antibodies with alpha-actinin and nephritogenic potential. Arthritis Rheum. 52 522-530.
164. C.E. Zielinski, S.N. Jacob, F. Bouzahzah, B.E. Ehrlich and J. Craft (2005) Naive CD4+ T cells from lupus-prone Fas-intact MRL mice display TCR-mediated hyper-proliferation due to intrinsic threshold defects in activation. J. Immunol. 174 5100-5109.